Hemp Science

  • CBD to the Rescue
    Life-threatening side effects from pharmaceuticals led one man to try cannabis. In this testimonial, he shares how cannabis helped him overcome refractory lockjaw and severe nerve pain.
  • Slow Progress for Medical Cannabis in the UK
    November 1, 2018, was a day for celebration. With one stroke, the British government finally cast aside years of outdated dogma, moving ‘Cannabis Based Medicinal Products’ from Schedule 1 to Schedule 2. Unfortunately, a year has passed and only a handful of patients have actually been prescribed cannabis.
  • Is CBD Toxic to the Liver?
    The huge popularity of cannabidiol has helped to destigmatize the plant and restore its reputation as an important medicinal herb. But bogus science and inept reporting continue to distort how we understand the benefits and risks of CBD and cannabis.
  • Sex and Cannabis
    From suppositories and lubes to massage oils and vape pens, there’s no shortage of cannabis products on the market that supposedly increase libido. But what do we actually know about the relationship between cannabis and sex?
  • Predicting Preterm Labor by Measuring Endocannabinoids
    The endocannabinoid system is increasingly recognized for its involvement in uterine function. Scientists have recently shown that anandamide levels could be a novel and non-invasive way to predict preterm labor.
  • Cannabis Instead of Polypharmacy?
    Polypharmacy - the use of five or more medications on a daily basis - is a modern-day health crisis. Could cannabis be the safer alternative prescribers and patients are looking for?
  • It's Never Too Late to Start Using Medical Cannabis
    Cannabis geriatrics and age-related pathologies were major topics at this year’s International Association of Cannabinoid Medicines. Seniors are currently the fastest-growing demographic of cannabis users worldwide, but is cannabis safe for the elderly? What might be the benefits?
  • Project CBD releases special report on synthetic cannabinoids and vaping-related lung injuries
    The jury is out on the culprit(s) behind the recent outbreak of vaping related lung injury. In this special report, Project CBD’s Chief Science writer, Adrian Devitt-Lee, suggests that synthetic cannabinoids could be partially responsible.
  • Cannabis Therapy for Seizures in Animals
    The use of cannabis as medicine for animals has been getting a lot attention in the medical, scientific, and pet owning communities. One of the potential uses showing the most promise is in the treatment of seizures. Does it work as well for pets as it does for people?
  • CBD Does Not Go Better with Coke
    Late last year, Bloomberg reported that Coca-Cola was in serious talks to develop a CBD-infused beverage. High sugar diets, like those that include drinking a lot of sugary beverages, have been linked to a host of health issues. Does it really make sense to add CBD to the mix?
  • Resources: Vaping Related Lung Injury
    VAPING-RELATED LUNG INJURIES
  • Using Cannabis to Treat Cancer
    How close are we to an approved cannabis therapy for cancer? Medical cannabis science pioneer Dr. Manuel Guzman discusses the successes and challenges towards acceptance in the medical community.
  • Cannabinoids for Scleroderma
    Two compounds that target the endocannabinoid system are currently in development to treat scleroderma – and they’re already in clinical trials. Pharmaceutical researchers have their sights set on developing a drug that bypasses CB1 while boosting CB2. Referred to as a “selective CB2 agonist,” such a compound would appear to have potential as a treatment for scleroderma.
  • Better Than Cannabis?
    Research on the effects of cannabis led directly to the discovery of a major biochemical signaling system in the human body – the endocannabinoid system – which plays a pivotal role in regulating a wide range of physiological processes. Here are ten strategies that scientists are currently pursuing in an effort to harness the healing potential of the endocannabinoid system.
  • What Should We Do About Vaping?
    Rather than banning an entire product category – be it vapes or edibles – state health officials should implement a rigorous regulatory program that prioritizes public health and raises the safety standards for all edibles and food supplements.
  • Is CBD an Endocannabinoid Reuptake Inhibitor?
    Project CBD speaks with Matt Elmes, PhD, director of new product development at CannaCraft, about his post-doctoral research on CBD, fatty acid transport molecules, and the endocannabinoid system.
  • CBD Survey Results: Cultivating Wellness
    Who is using CBD and why? Despite the huge public interest in CBD products, and an endless stream of media stoking that fire, there have been limited efforts to figure out exactly how and why people are using this darling compound of the cannabis world.
  • The CBD Silly Season
    With current market predictions estimating CBD sales at over $20 billion in the U.S. alone, it’s no wonder other business sectors want to get in on the act. But it’s the addition of CBD to textiles and clothing that has got industry insiders scratching their heads. How did CBD suddenly get added into everything?
  • When Bob Dylan Turned the Beatles On To Marijuana
    On August 28th, 1964 Bob Dylan introduced the Beatles to cannabis for their first time. And the rest is more than just rock ‘n’ roll history.
  • Cannabis and Incontinence
    Because bladder control falls mostly to the central nervous system, it’s no surprise that cannabis may present novel and effective treatment options. We know that cannabinoid receptors are profusely expressed in both the central nervous system and peripheral nervous system. And we also know that these receptors are activated by endogenous compounds as well as components of the cannabis plant. Thanks to ongoing research on cannabis and MS, quite a bit of useful data about incontinence has been collected, both in preclinical studies and a few small clinical trials.